CAR T Cell Therapy: Engineering the Immune System to Fight Pediatric Cancer

Take a closer look at the role of T cells in cancer therapy and the development of chimeric antigen receptor (CAR) T cells. Explore the early successes and challenges in the development of CAR T cell therapy in pediatric leukemia. Presented by Dr. Amanda Li, Clinical Assistant Professor, Department of Pediatrics, UBC; Attending Physician, BC Children's Hospital. (2019)

Researcher Amanda Li

Research Areas

Cancer in Children

Cancer

Cancer Immunotherapy

Recent News See all

BCCHR research could help set new international standard for young children receiving bone marrow transplants

The findings from a BCCHR study played a part in integrating the multiple breath washout test into recent recommendations to screen children for pulmonary chronic graft-versus-host disease, a lung complication that can affect children who undergo a bone marrow transplant.

Continue reading BCCHR research could help set new international standard for young children receiving bone marrow transplants

Beyond access: Moving towards equity in pediatric type 1 diabetes care

Managing type 1 diabetes (T1D) can be challenging for patients, especially those from marginalized populations facing structural inequities. Families affected by T1D often grapple with managing a complex condition that requires continuous monitoring, timely insulin administration, and strict adherence to treatment plans. These challenges can be exacerbated for patients in socioeconomically deprived communities, where access to care and diabetes technology is often limited.

Continue reading Beyond access: Moving towards equity in pediatric type 1 diabetes care

New study makes key findings in potential advancement of diabetes cure

New research published in Nature Communications, identifies a key molecule that might be critical for the development of stem cell-based therapies for treating type 1 diabetes.

Continue reading New study makes key findings in potential advancement of diabetes cure

Pneumonia and malaria: Innovations tackle leading threats to children under five

Globally, pneumonia and malaria are among the leading causes of death for children under five, due in part to health-care resource gaps in low- and middle-income countries. New BCCHR investigator and pediatric infectious diseases expert Dr. Michael T. Hawkes is developing diagnostic and treatment tools to address these shortages.

Continue reading Pneumonia and malaria: Innovations tackle leading threats to children under five

Dr. Kirk Schultz awarded the 2024 Geoffrey L. Hammond Lectureship

Dr. Kirk Schultz, an investigator at BC Children’s Hospital Research Institute, has been awarded the 2024 Geoffrey L. Hammond Lectureship in recognition of his leadership and significant contributions to improving the health and well-being of children in British Columbia and around the world.

Continue reading Dr. Kirk Schultz awarded the 2024 Geoffrey L. Hammond Lectureship

Donate to Research

We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.

Give Now

CAR T Cell Therapy: Engineering the Immune System to Fight Pediatric Cancer

CAR T Cell Therapy: Engineering the Immune System to Fight Pediatric Cancer

Recent News See all

BCCHR research could help set new international standard for young children receiving bone marrow transplants

Beyond access: Moving towards equity in pediatric type 1 diabetes care

New study makes key findings in potential advancement of diabetes cure

Pneumonia and malaria: Innovations tackle leading threats to children under five

Dr. Kirk Schultz awarded the 2024 Geoffrey L. Hammond Lectureship

Donate to Research

Stay in the know